Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein receptors (BMPRs) are transmembrane serine/threonine kinase receptors that mediate the cellular effects of bone morphogenetic proteins (BMPs), members of the transforming growth factor-beta (TGF-β) superfamily. BMPs are secreted cytokines involved in a wide range of biological processes, including embryonic development, cell differentiation, proliferation, apoptosis, and especially bone and cartilage formation. BMPRs function as heteromeric complexes composed of type I (ALK2/ACVR1, ALK3/BMPRIA, ALK6/BMPRIB) and type II (BMPRII) receptors. Upon ligand binding, the receptors phosphorylate SMAD proteins to regulate gene expression relevant to osteogenesis and other developmental processes. Disruptions or mutations in BMPR genes can lead to developmental disorders or diseases such as pulmonary arterial hypertension or impaired bone growth.
Serine/threonine kinase activity, SMAD phosphorylation, gene regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Morphogenetic Protein Receptor.